Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kodiak Sciences Inc.(KOD) | 0 | 420,000 | +420,000 | $0 | $39.82M | 11.80% | +$39.82M |
| C4 Therapeutics Inc | 0 | 9,318,683 | +9,318,683 | $0 | $31.03M | 9.20% | +$31.03M |
| Cogent Biosciences, Inc.(COGT) | 0 | 915,000 | +915,000 | $0 | $29.30M | 8.68% | +$29.30M |
| Silence Therapeutics plcADS(SLN) | 0 | 2,085,000 | +2,085,000 | $0 | $22.79M | 6.75% | +$22.79M |
| Zentalis Pharmaceuticals Inc | 0 | 6,827,905 | +6,827,905 | $0 | $18.91M | 5.61% | +$18.91M |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 425,000 | +425,000 | $0 | $17.25M | 5.11% | +$17.25M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 785,000 | +785,000 | $0 | $14.17M | 4.20% | +$14.17M |
| Oric Pharmaceuticals Inc | 0 | 1,000,000 | +1,000,000 | $0 | $13.47M | 3.99% | +$13.47M |
| Relmada Therapeutics Inc | 0 | 3,500,000 | +3,500,000 | $0 | $13.20M | 3.91% | +$13.20M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 340,000 | +340,000 | $0 | $12.94M | 3.84% | +$12.94M |
| Pharvaris N.V.(PHVS) | 0 | 400,000 | +400,000 | $0 | $12.69M | 3.76% | +$12.69M |
| Adlai Nortye Group LtdADS | 0 | 764,876 | +764,876 | $0 | $12.24M | 3.63% | +$12.24M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 305,000 | +305,000 | $0 | $9.85M | 2.92% | +$9.85M |
| Inventiva SaADS | 0 | 2,400,000 | +2,400,000 | $0 | $8.86M | 2.62% | +$8.86M |
| Avalo Therapeutics Inc | 0 | 450,000 | +450,000 | $0 | $6.90M | 2.04% | +$6.90M |
| Aclaris Therapeutics Inc | 0 | 1,200,000 | +1,200,000 | $0 | $6.31M | 1.87% | +$6.31M |
| Assembly Biosciences Inc | 0 | 225,000 | +225,000 | $0 | $5.29M | 1.57% | +$5.29M |
| Adagene IncADS | 0 | 1,616,618 | +1,616,618 | $0 | $5.17M | 1.53% | +$5.17M |
| Crescent Biopharma Inc. | 0 | 350,000 | +350,000 | $0 | $5.11M | 1.51% | +$5.11M |
| Yarrow Bioscience Inc | 0 | 225,000 | +225,000 | $0 | $5.07M | 1.50% | +$5.07M |
| Zura Bio LtdCL A | 0 | 1,200,000 | +1,200,000 | $0 | $4.99M | 1.48% | +$4.99M |
| Tcgx Acquisition CorpCL A | 0 | 370,220 | +370,220 | $0 | $4.63M | 1.37% | +$4.63M |
| Contineum Therapeutics IncCL A | 0 | 323,570 | +323,570 | $0 | $4.34M | 1.29% | +$4.34M |
| Inhibikase Therapeutics Inc | 0 | 2,000,000 | +2,000,000 | $0 | $4.11M | 1.22% | +$4.11M |
| Palisade Bio Inc | 0 | 3,000,000 | +3,000,000 | $0 | $4.05M | 1.20% | +$4.05M |
| Tango Therapeutics, Inc.(TNGX) | 0 | 150,000 | +150,000 | $0 | $3.74M | 1.11% | +$3.74M |
| Janux Therapeutics Inc | 0 | 215,000 | +215,000 | $0 | $3.72M | 1.10% | +$3.72M |
| Savara Inc.(SVRA) | 0 | 675,000 | +675,000 | $0 | $3.48M | 1.03% | +$3.48M |
| Quince Therapeutics Inc | 0 | 90,000 | +90,000 | $0 | $2.79M | 0.83% | +$2.79M |
| Jatt Iii Acquisition Corp | 0 | 250,000 | +250,000 | $0 | $2.75M | 0.82% | +$2.75M |
| Scynexis Inc | 0 | 515,045 | +515,045 | $0 | $2.54M | 0.75% | +$2.54M |
| Alx Oncology Hldgs Inc | 0 | 1,400,000 | +1,400,000 | $0 | $1.95M | 0.58% | +$1.95M |
| Lipocine Inc New | 0 | 810,000 | +810,000 | $0 | $1.78M | 0.53% | +$1.78M |
| Pepgen Inc | 0 | 600,000 | +600,000 | $0 | $1.45M | 0.43% | +$1.45M |
| Jatt Ii Acquisition Corp | 0 | 65,000 | +65,000 | $0 | $730.9K | 0.22% | +$730.9K |